Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-17-003599
Filing Date
2017-01-23
Accepted
2017-01-23 18:03:04
Documents
1
Period of Report
2017-01-20

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 3940
  Complete submission text file 0001104659-17-003599.txt   5391
Mailing Address C/O TOLERRX INC 300 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
ONSI DOUGLAS E (Reporting) CIK: 0001270185 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37990 | Film No.: 17542119

Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Issuer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations